What Scientists Can Do To Fight The Frankenstein Myth

In his comments at the annual meeting of the American Association for the Advancement of Science (AAAS) two weeks ago, President Bill Clinton echoed a refrain from his State of the Union address in which he tempered his enthusiasm for scientific progress with a call to "see that science serves humanity, and not the other way around." This disquieting sentiment-that science, like Dr. Frankenstein's monster, is poised to wreak havoc on its creator-has a currency today that should alarm us as scie

Written byMildred Dresselhaus
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

In his comments at the annual meeting of the American Association for the Advancement of Science (AAAS) two weeks ago, President Bill Clinton echoed a refrain from his State of the Union address in which he tempered his enthusiasm for scientific progress with a call to "see that science serves humanity, and not the other way around." This disquieting sentiment-that science, like Dr. Frankenstein's monster, is poised to wreak havoc on its creator-has a currency today that should alarm us as scientists. More than alarm us, it should spur us to action.

Yes, it is vitally important that science and technology serve humanity. But this can occur only in an atmosphere of hope and trust rather than suspicion and fear.

AAAS, which celebrates its 150th anniversary this year, has always advocated an open dialogue between scientists and the rest of society so as to-in the words of Joseph Henry, AAAS ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies